Acute Management of Hypertension Following Intracerebral Hemorrhage

Critical Care Nursing Quarterly
J Tyler HallerKeaton S Smetana

Abstract

Intracerebral hemorrhage (ICH) is responsible for approximately 15% of strokes annually in the United States, with nearly 1 in 3 of these patients dying without ever leaving the hospital. Because this disproportionate mortality risk has been stagnant for nearly 3 decades, a main area of research has been focused on the optimal strategies to reduce mortality and improve functional outcomes. The acute hypertensive response following ICH has been shown to facilitate ICH expansion and is a strong predictor of mortality. Rapidly reducing blood pressure was once thought to induce cerebral ischemia, though has been found to be safe in certain patient populations. Clinicians must work quickly to determine whether specific patient populations may benefit from acute lowering of systolic blood pressure (SBP) following ICH. This review provides nurses with a summary of the available literature on blood pressure control following ICH. It focuses on intravenous and oral antihypertensive medications available in the United States that may be utilized to acutely lower SBP, as well as medications outside of the antihypertensive class used during the acute setting that may reduce SBP.

References

Jan 1, 1977·British Heart Journal·D A RichardsE J Knight
Jan 1, 1979·Neurosurgery·M H WeissT Kurze
Sep 1, 1976·Anesthesiology·J H Tinker, J D Michenfelder
Feb 1, 1991·Annals of Emergency Medicine·P J Donovan, D Cline
Jan 1, 1986·Journal of Cardiovascular Pharmacology·T UngerR E Lang
Dec 1, 1988·Clinical Pharmacology and Therapeutics·B E GibsonR F Cucchiara
Jan 1, 1986·British Journal of Clinical Pharmacology·J G KellyW D Cooper
Jan 1, 1988·British Journal of Anaesthesia·M A ClaeysF Camu
Jul 10, 1985·The American Journal of Cardiology·J Abrams
Mar 1, 1967·Diseases of the Chest·J S Karliner
Jan 1, 1984·British Journal of Clinical Pharmacology·R O DaviesJ F Walker
Dec 1, 1980·Clinical Pharmacology and Therapeutics·T M LuddenM S Lin
Jan 1, 1995·Stroke; a Journal of Cerebral Circulation·B K DandapaniR C Duncan
Sep 1, 1994·Journal of Clinical Anesthesia·F E CunninghamC E Laurito
Jun 1, 1996·Neurology·T R BrowneM A Eldon
Jul 1, 1996·The American Journal of Emergency Medicine·L BinderA Cuetter
Oct 1, 1996·Stroke; a Journal of Cerebral Circulation·S KazuiT Yamaguchi
Jan 1, 1997·Stroke; a Journal of Cerebral Circulation·T BrottJ Khoury
Aug 15, 1998·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·E GrossmanF H Messerli
Mar 24, 2000·Drugs·N BhanaK J McClellan
Apr 27, 2001·Age and Ageing·K Abou-HatabK Woodhouse
May 25, 2001·European Journal of Clinical Pharmacology·K Abou-HatabK Woodhouse
Apr 6, 2002·Stroke; a Journal of Cerebral Circulation·Hidetoshi KasuyaTomokastu Hori
Feb 27, 2003·Clinical Pharmacokinetics·Satoru Hashimoto, Atsuko Kobayashi
Jul 25, 2003·Drugs of Today·G Brock
Feb 18, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·H S Markus

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.